Search results
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows By Reuters
Investing.com· 5 days agoThe data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
Colorado Springs Gazette· 5 days agoThe data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
Reuters· 5 days agoAbout one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight...
Kelly Clarkson Talks Losing ‘A Lot’ of Weight on Prescription Medication: ‘Everybody Thinks It’s...
Billboard via Yahoo News· 2 days agoClarkson said the unnamed drug she’s taking “aids in helping break down the sugar [because]...
Aetna vs. Anthem: Medicare Advantage Comparison - NerdWallet
Nerdwallet· 2 days agoAetna offers Medicare Advantage plans in more states and covers nearly twice as many members as...
Recent Developments in Pharmacy-Related Legislation and Regulations | JD Supra
JD Supra· 1 day agoOver the last two months, there has been a steady influx of regulatory and legislative efforts regarding drug pricing and the pharmacy industry. In April, the U.S. Government ...
Short-Term Market Volatility Could Provide Long-Term Investing Opportunities
Morningstar· 6 days agoWhy Morningstar thinks Apple could turn it around for 2025. Plus, the Federal Reserve is delaying...
What Medicare beneficiaries need to know about generic medications
Fortune· 1 day agoJust ask Susan Jaquith, a retired teacher in Wilson, N.C., who’d been paying about $2,000 a year for a brand-name blood pressure medication and wanted to switch to a less ...
Kaiser Permanente vs. Anthem: Medicare Advantage Comparison - NerdWallet
Nerdwallet· 2 days agoKaiser Permanente’s star ratings are higher, while Anthem's member experience scores are better....
The Oncology Institute Inc (TOI) (Q1 2024) Earnings Call Transcr
Guru Focus· 2 days agoRevenue Growth: Q1 2024 revenue increased by 24% year-over-year.Oral Drug Revenue: Grew 64% in Q1 2024 compared to Q1 2023.Capitation Revenue: Estimated full y